Duchenne muscular dystrophy research hub
4 indexed studies · 2 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, placebo controlled study
This study looks at whether a medicine called Metoprolol can help prevent heart problems in young people with Duchenne Muscular Dystrophy. It compares Metoprolol to a dummy medicine to see if it makes a difference to heart strength.
Poland - active not recruiting
Enlighten Study: The EV-ICD Post Approval Registry
This study, called Enlighten, is looking at how a device called an EV-ICD works in everyday life after it's been approved and is being used by patients. It checks its safety and how well it treats fast, abnormal heart rhythms.
United States · Austria · Belgium - recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
This study looks at how well a small heart monitor, called an Implantable Cardiac Monitor (ICM), works in real life for patients in the UK. It helps doctors understand its performance and safety over time, especially for conditions like irregular heartbeats or fainting spells.
Australia · Czechia · France - recruiting
Registry of Device Implantation
This study looks at how well heart devices, like pacemakers, work and if they're safe. These devices treat problems like a slow or fast heartbeat. Researchers are collecting information from patients to see what helps them get better and avoid problems, aiming to improve future care.
Germany